Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Short-term Investments (2024 - 2025)

Historic Short-term Investments for Immunocore Holdings (IMCR) over the last 2 years, with Q3 2025 value amounting to $393.9 million.

  • Immunocore Holdings' Short-term Investments rose 836.97% to $393.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $393.9 million, marking a year-over-year increase of 836.97%. This contributed to the annual value of $364.6 million for FY2024, which is N/A changed from last year.
  • Per Immunocore Holdings' latest filing, its Short-term Investments stood at $393.9 million for Q3 2025, which was up 836.97% from $394.9 million recorded in Q2 2025.
  • Immunocore Holdings' Short-term Investments' 5-year high stood at $394.9 million during Q2 2025, with a 5-year trough of $354.6 million in Q2 2024.